| 2022 | Updated efficacy and safety of entrectinib in patients (pts) with NTRK fusion-positive (NTRK-fp) NSCLC | ANNALS OF ONCOLOGY |
| 2021 | Updated Integrated Analysis of the Efficacy and Safety of Entrectinib in Locally Advanced or Metastatic ROS1 Fusion-Positive Non-Small-Cell Lung Cancer | JOURNAL OF CLINICAL ONCOLOGY |
| 2022 | Updated Integrated Analysis of the Efficacy and Safety of Entrectinib in Patients With NTRK Fusion-Positive Solid Tumors
| CLINICAL CANCER RESEARCH |
| 2022 | Updated Overall Survival of Ribociclib plus Endocrine Therapy versus Endocrine Therapy Alone in Pre- and Perimenopausal Patients with HR+/HER2- Advanced Breast Cancer in MONALEESA-7: A Phase III Randomized Clinical Trial
| CLINICAL CANCER RESEARCH |
| 2021 | Updated recommendations for the treatment of venous thromboembolism
| BLOOD RESEARCH |
| 2018 | Updated treatment strategies for intestinal Behcet's disease
| KOREAN JOURNAL OF INTERNAL MEDICINE |
| 2022 | Updates on conventional therapies for inflammatory bowel diseases: 5-aminosalicylates, corticosteroids, immunomodulators, and anti-TNF-α
| KOREAN JOURNAL OF INTERNAL MEDICINE |
| 2020 | Upfront autologous hematopoietic stem cell transplantation for high-risk patients with double-expressor diffuse large B cell lymphoma | ANNALS OF HEMATOLOGY |
| 2021 | Upfront chemotherapy and short-course radiotherapy with delayed surgery for locally advanced rectal cancer with synchronous liver metastases | EJSO |
| 2020 | Upfront radical surgery with total mesorectal excision followed by adjuvant FOLFOX chemotherapy for locally advanced rectal cancer (TME-FOLFOX): an open-label, multicenter, phase II randomized controlled trial
| TRIALS |
| 2011 | Upfront systemic chemotherapy and preoperative short-course radiotherapy with delayed surgery for locally advanced rectal cancer with distant metastases.
| RADIATION ONCOLOGY |
| 2016 | Upfront Systemic Chemotherapy and Short-Course Radiotherapy with Delayed Surgery for Locally Advanced Rectal Cancer with Distant Metastases: Outcomes, Compliance, and Favorable Prognostic Factors
| PLOS ONE |
| 2019 | Upregulated microRNA-193a-3p is responsible for cisplatin resistance in CD44(+) gastric cancer cells
| CANCER SCIENCE |
| 2016 | Upregulated Neuro-oncological Ventral Antigen 1 (NOVA1) Expression Is Specific to Mature and Immature T- and NK-Cell Lymphomas.
| JOURNAL OF PATHOLOGY AND TRANSLATIONAL MEDICINE |
| 2015 | Upregulated, 7q21-22 amplicon candidate gene SHFM1 confers oncogenic advantage by suppressing p53 function in gastric cancer | CELLULAR SIGNALLING |
| 2002 | Upregulation of extracellular matrix metalloproteinase inducer(EMMPRIN) and gelatinase in human atherosclerosis infected with Chlamydia pneumoniae
| EXPERIMENTAL AND MOLECULAR MEDICINE |
| 2012 | Upregulation of hepatic LRP1 by rosiglitazone: a possible novel mechanism of the beneficial effect of thiazolidinediones on atherogenic dyslipidemia | JOURNAL OF MOLECULAR ENDOCRINOLOGY |
| 2016 | Upregulation of long noncoding RNA LOC100507661 promotes tumor aggressiveness in thyroid cancer. | MOLECULAR AND CELLULAR ENDOCRINOLOGY |
| 2020 | Upregulation of Peroxiredoxin-2 in Well-Differentiated Pancreatic Neuroendocrine Tumors and Its Utility as a Biomarker for Predicting the Response to Everolimus
| ANTIOXIDANTS |
| 2005 | Upstream regulation of matrix metalloproteinase by EMMPRIN; extracellular matrix metalloproteinase inducer in advanced atherosclerotic plaque | ATHEROSCLEROSIS |
